-
Taking Stock of CAR T-Cell Therapy
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
The View From a CAR T-Cell Clinical Trial
After exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
by Pamela Rafalow Grossman
-
Forward Look
Drug Combinations for Advanced MelanomaResearchers find that when treating metastatic melanoma, timing is everything.
by Erin O'Donnell
-
Q&A
Show Me You CareTheresa Brown, who was a nurse when she was diagnosed with breast cancer, writes about deep gaps in her own care.
by Marci A. Landsmann
-
Healthy Habits
Signs of Skin CancerRegularly checking your skin is crucial to catching skin cancer early.
by Tara Santoro
-
Comorbidity: Treating the Whole Patient
Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
by Eric Fitzsimmons
-
Survivor Profile
Control What You CanBusiness leader CiCi Rojas takes life lessons from lymphoma.
by Lindsey Konkel Neabore
-
Forward Look
FDA Designates Two Cigarettes as Modified Risk Tobacco ProductsCritics warn that lower nicotine content in the cigarettes may not translate into better odds of quitting.
by Carisa Brewster
-
Facts and Stats
Driving Down Lung Cancer DeathsScreenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
by Eric Fitzsimmons
-
Forward Look
Crowdsourcing SupportAfter struggling to understand her treatment options for multiple myeloma, Jenny Ahlstrom started a virtual platform for patients to gather information about blood cancers.
by Allison Futterman
Cancer Talk
Treatment Combination Improves Survival in EGFR-positive Lung Cancer
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
